Title: TBECH, 1,2-dibromo-4-(1,2 dibromoethyl) cyclohexane, alters androgen receptor regulation in response to mutations associated with prostate cancer.
Journal: Toxicology and applied pharmacology20160915
Title: In silico discovery of androgen receptor antagonists with activity in castration resistant prostate cancer.
Journal: Molecular endocrinology (Baltimore, Md.)20121101
Title: Discovery of diarylhydantoins as new selective androgen receptor modulators.
Journal: Journal of medicinal chemistry20121011
Title: Steroid derivatives as pure antagonists of the androgen receptor.
Journal: The Journal of steroid biochemistry and molecular biology20121001
Title: Nilutamide.
Journal: Acta crystallographica. Section E, Structure reports online20120301
Title: Anti-androgen effects of cypermethrin on the amino- and carboxyl-terminal interaction of the androgen receptor.
Journal: Toxicology20120226
Title: Current and emerging treatment options for castration-resistant prostate cancer: a focus on immunotherapy.
Journal: Journal of clinical immunology20120201
Title: N-[3-(4-Fluoro-benz-yl)-2,4-dioxo-1,3-diaza-spiro-[4.5]dec-8-yl]-2-methyl-benzene-sulfonamide.
Journal: Acta crystallographica. Section E, Structure reports online20120101
Title: N-{3-[2-(4-Fluoro-phen-oxy)eth-yl]-2,4-dioxo-1,3-diaza-spiro-[4.5]decan-7-yl}-4-meth-oxy-benzene-sulfonamide.
Journal: Acta crystallographica. Section E, Structure reports online20120101
Title: Redefining hormone sensitive disease in advanced prostate cancer.
Journal: Advances in urology20120101
Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Journal: PLoS computational biology20111201
Title: Inhibitors of androgen receptor activation function-2 (AF2) site identified through virtual screening.
Journal: Journal of medicinal chemistry20110922
Title: Chemical genomics profiling of environmental chemical modulation of human nuclear receptors.
Journal: Environmental health perspectives20110801
Title: Efficacy of alternative antiandrogen therapy for prostate cancer that relapsed after initial maximum androgen blockade.
Journal: Korean journal of urology20110701
Title: N-{3-[2-(4-Fluoro-phen-oxy)eth-yl]-2,4-dioxo-1,3-diaza-spiro-[4.5]decan-7-yl}-4-methyl-benzamide.
Journal: Acta crystallographica. Section E, Structure reports online20110601
Title: Two panels of steroid receptor luciferase reporter cell lines for compound profiling.
Journal: Combinatorial chemistry & high throughput screening20110501
Title: Drug safety is a barrier to the discovery and development of new androgen receptor antagonists.
Journal: The Prostate20110401
Title: Castration-resistant prostate cancer: targeted therapies and individualized treatment.
Journal: The oncologist20110301
Title: Current treatment strategies for castration-resistant prostate cancer.
Journal: Korean journal of urology20110301
Title: Androgen receptor-mediated regulation of the anti-atherogenic enzyme CYP27A1 involves the JNK/c-jun pathway.
Journal: Archives of biochemistry and biophysics20110215
Title: Arylpiperazines for management of benign prostatic hyperplasia: design, synthesis, quantitative structure-activity relationships, and pharmacokinetic studies.
Journal: Journal of medicinal chemistry20110113
Title: Neoadjuvant androgen deprivation for prostate volume reduction: the optimal duration in prostate cancer radiotherapy.
Journal: Urologic oncology20110101
Title: Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments.
Journal: OncoTargets and therapy20110101
Title: Six-month gonadotropin releasing hormone (GnRH) agonist depots provide efficacy, safety, convenience, and comfort.
Journal: Cancer management and research20110101
Title: Control of prostate cancer associated with withdrawal of a supplement containing folic acid, L-methyltetrahydrofolate and vitamin B12: a case report.
Journal: Journal of medical case reports20110101
Title: Resistance to cancer treatment: the role of somatic genetic events and the challenges for targeted therapies.
Journal: Frontiers in pharmacology20110101
Title: New insights into the androgen-targeted therapies and epigenetic therapies in prostate cancer.
Journal: Prostate cancer20110101
Title: Effect of Turkish propolis extracts on proteome of prostate cancer cell line.
Journal: Proteome science20110101
Title: Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer.
Journal: Drug, healthcare and patient safety20110101
Title: Molecular targets for radiation oncology in prostate cancer.
Journal: Frontiers in oncology20110101
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters20101101
Title: Activity of antiandrogens against juvenile and adult Schistosoma mansoni in mice.
Journal: The Journal of antimicrobial chemotherapy20100901
Title: Words of wisdom. Re: Does oral antiandrogen use before leuteinizing hormone-releasing therapy in patients with metastatic prostate cancer prevent clinical consequences of a testosterone flare? Oh WK, Landrum MB, Lamont EB, et al. Urology 2010;75:642-7.
Journal: European urology20100801
Title: Involvement of androgen receptor in nitric oxide production induced by icariin in human umbilical vein endothelial cells.
Journal: FEBS letters20100603
Title: Androgen receptor-dependent activation of endothelial nitric oxide synthase in vascular endothelial cells: role of phosphatidylinositol 3-kinase/akt pathway.
Journal: Endocrinology20100401
Title: Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor.
Journal: Journal of biomedical science20100101
Title: A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899.
Journal: Journal of translational medicine20100101
Title: The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model.
Journal: Biology direct20100101
Title: Maximal androgen blockade for advanced prostate cancer.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India20100101
Title: Hormonal therapy of prostate cancer.
Journal: Progress in brain research20100101
Title: Alternative strategies for the treatment of classical congenital adrenal hyperplasia: pitfalls and promises.
Journal: International journal of pediatric endocrinology20100101
Title: Down-regulation of phosphoglucomutase 3 mediates sulforaphane-induced cell death in LNCaP prostate cancer cells.
Journal: Proteome science20100101
Title: Fasting and cancer treatment in humans: A case series report.
Journal: Aging20091201
Title: Efficacy of salvage radiotherapy plus 2-year androgen suppression for postradical prostatectomy patients with PSA relapse.
Journal: International journal of radiation oncology, biology, physics20091115
Title: Prospective study evaluating postoperative radiotherapy plus 2-year androgen suppression for post-radical prostatectomy patients with pathologic T3 disease and/or positive surgical margins.
Journal: International journal of radiation oncology, biology, physics20091001
Title: Integrating statistical predictions and experimental verifications for enhancing protein-chemical interaction predictions in virtual screening.
Journal: PLoS computational biology20090601
Title: Fulminant hepatic failure due to nilutamide hepatotoxicity.
Journal: Digestive diseases and sciences20090401
Title: CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer.
Journal: British journal of cancer20090310
Title: Impact level of dihydrotestosterone on the hypothalamic-pituitary-leydig cell axis in men.
Journal: International journal of andrology20090201
Title: Genotoxic and endocrine activities of bis(hydroxyphenyl)methane (bisphenol F) and its derivatives in the HepG2 cell line.
Journal: Toxicology20090108
Title: Role of maximum androgen blockade in advanced prostate cancer.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India20090101
Title: Watchful waiting beats androgen deprivation therapy in early prostate cancer.
Journal: Journal of the National Cancer Institute20081105
Title: Testosterone recovery after prolonged androgen suppression in patients with prostate cancer.
Journal: The Journal of urology20081001
Title: Analysis of overall survival in patients with nonmetastatic castration-resistant prostate cancer treated with vaccine, nilutamide, and combination therapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research20080715
Title: Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426).
Journal: Cancer20080601
Title: Delayed dark adaptation caused by nilutamide.
Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society20080601
Title: Screening of 397 chemicals and development of a quantitative structure--activity relationship model for androgen receptor antagonism.
Journal: Chemical research in toxicology20080401
Title: Maximal androgen blockade for advanced prostate cancer.
Journal: Best practice & research. Clinical endocrinology & metabolism20080401
Title: Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide.
Journal: Journal of medicinal chemistry20080327
Title: The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens.
Journal: BMC cell biology20080101
Title: FAF-Drugs2: free ADME/tox filtering tool to assist drug discovery and chemical biology projects.
Journal: BMC bioinformatics20080101
Title: Androgen receptor functional analyses by high throughput imaging: determination of ligand, cell cycle, and mutation-specific effects.
Journal: PloS one20080101
Title: A dramatic, objective antiandrogen withdrawal response: case report and review of the literature.
Journal: Journal of hematology & oncology20080101
Title: Strategies for prostate cancer prevention: Review of the literature.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India20080101
Title: Role of vaccine therapy in cancer: biology and practice.
Journal: Current oncology (Toronto, Ont.)20071201
Title: Combined androgen blockade in advanced prostate cancer: looking back to move forward.
Journal: Clinical genitourinary cancer20070901
Title: A bifunctional colchicinoid that binds to the androgen receptor.
Journal: Molecular cancer therapeutics20070801
Title: A novel synthetic compound that interrupts androgen receptor signaling in human prostate cancer cells.
Journal: Molecular cancer therapeutics20070701
Title: Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors.
Journal: The Prostate20070601
Title: Long-term effectiveness of luteinizing hormone-releasing hormone agonist or antiandrogen monotherapy in elderly men with localized prostate cancer (T1-2): a retrospective study.
Journal: Asian journal of andrology20070301
Title: Signaling pathway of nitric oxide production induced by ginsenoside Rb1 in human aortic endothelial cells: a possible involvement of androgen receptor.
Journal: Biochemical and biophysical research communications20070216
Title: Antiandrogenic activity of pyrethroid pesticides and their metabolite in reporter gene assay.
Journal: Chemosphere20070101
Title: In silico prediction of pregnane X receptor activators by machine learning approaches.
Journal: Molecular pharmacology20070101
Title: New therapeutic targets in the treatment of prostate cancer.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India20070101
Title: Ginsenoside Re, a main phytosterol of Panax ginseng, activates cardiac potassium channels via a nongenomic pathway of sex hormones.
Journal: Molecular pharmacology20061201
Title: Role of 5 alpha-reductase inhibitors in the management of prostate cancer.
Journal: Clinical interventions in aging20061201
Title: Bioactivation and hepatotoxicity of nitroaromatic drugs.
Journal: Current drug metabolism20061001
Title: [Keyrole of endocrinology in the victory against prostate cancer].
Journal: Bulletin du cancer20060901
Title: Antiandrogen treatments in locally advanced prostate cancer: are they all the same?
Journal: Journal of cancer research and clinical oncology20060801
Title: GREB1 is a novel androgen-regulated gene required for prostate cancer growth.
Journal: The Prostate20060601
Title: Maximal androgen blockade for the treatment of metastatic prostate cancer--a systematic review.
Journal: Current oncology (Toronto, Ont.)20060601
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501
Title: Combined androgen blockade: an update.
Journal: The Urologic clinics of North America20060501
Title: Recent progress in hormonal therapy for advanced prostate cancer.
Journal: Current opinion in urology20060501
Title: Androgen receptor is responsible for rat organic cation transporter 2 gene regulation but not for rOCT1 and rOCT3.
Journal: Pharmaceutical research20060401
Title: Androgenic and antiandrogenic effects and expression of androgen receptor in mouse embryonic stem cells.
Journal: Fertility and sterility20060401
Title: Metabolism of nilutamide in rat lung.
Journal: Biochemical pharmacology20060112
Title: Androgen receptor activities of p,p'-DDE, fenvalerate and phoxim detected by androgen receptor reporter gene assay.
Journal: Toxicology letters20060105
Title: The role of steroids in follicular growth.
Journal: Reproductive biology and endocrinology : RB&E20060101
Title: Prostate cancer PET bioprobes: synthesis of [18F]-radiolabeled hydroxyflutamide derivatives.
Journal: Bioorganic & medicinal chemistry20051115
Title: Mitochondrial permeability transition as a source of superoxide anion induced by the nitroaromatic drug nimesulide in vitro.
Journal: Free radical biology & medicine20051001
Title: Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer.
Journal: BJU international20051001
Title: A phase II study of nilutamide in men with prostate cancer after the failure of flutamide or bicalutamide therapy.
Journal: BJU international20051001
Title: Nontranscriptional regulation of cardiac repolarization currents by testosterone.
Journal: Circulation20050920
Title: Long-term side-effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II study.
Journal: BJU international20050901
Title: Antiandrogen, vaccine and combination therapy in patients with nonmetastatic hormone refractory prostate cancer.
Journal: The Journal of urology20050801
Title: [From the finger to the eye!...].
Journal: La Revue de medecine interne20050701
Title: Prediction of genotoxicity of chemical compounds by statistical learning methods.
Journal: Chemical research in toxicology20050601
Title: Intermittent androgen deprivation for biologic recurrence after radical prostatectomy: long-term experience.
Journal: Urology20050401
Title: Combined androgen blockade: the case for bicalutamide.
Journal: Clinical prostate cancer20050301
Title: Three-dimensional structure-activity relationships of nonsteroidal ligands in complex with androgen receptor ligand-binding domain.
Journal: Journal of medicinal chemistry20050224
Title: How are hemoglobin levels affected by androgen deprivation in non-metastatic prostate cancer patients?
Journal: The Canadian journal of urology20050201
Title: Prolonged response to nilutamide in a patient with stage D0.5 prostate cancer who previously failed androgen deprivation therapy.
Journal: American journal of therapeutics20050101
Title: Major impact of hormonal therapy in localized prostate cancer--death can already be an exception.
Journal: The Journal of steroid biochemistry and molecular biology20041201
Title: Distribution of nitroreductive activity toward nilutamide in rat.
Journal: Toxicology and applied pharmacology20041115
Title: Studies of targeting and intracellular trafficking of an anti-androgen doxorubicin-formaldehyde conjugate in PC-3 prostate cancer cells bearing androgen receptor-GFP chimera.
Journal: Journal of medicinal chemistry20041104
Title: Monotherapy in advanced prostate cancer: an overview.
Journal: Experimental oncology20040901
Title: Interstitial lung disease associated with drug therapy.
Journal: British journal of cancer20040801
Title: Steroid activities comparison of natural and food wrap compounds in human breast cancer cell lines.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association20040601
Title: Antiandrogen monotherapy: recommendations for the treatment of prostate cancer.
Journal: Urologia internationalis20040101
Title: Vaccine therapy for a patient with androgen-insensitive prostate cancer without evidence of measurable disease on scans.
Journal: American journal of therapeutics20040101
Title: Reduction of nilutamide by NO synthases: implications for the adverse effects of this nitroaromatic antiandrogen drug.
Journal: Chemical research in toxicology20031201
Title: [Fatal fulminating hepatitis induced by nilutamide].
Journal: Gastroenterologie clinique et biologique20031201
Title: Rational design and synthesis of androgen receptor-targeted nonsteroidal anti-androgen ligands for the tumor-specific delivery of a doxorubicin-formaldehyde conjugate.
Journal: Journal of medicinal chemistry20031120
Title: Steroids control the aromatase gene expression in purified germ cells from the adult male rat.
Journal: Journal of molecular endocrinology20030801
Title: Nilutamide as second line hormone therapy for prostate cancer after androgen ablation fails.
Journal: The Journal of urology20030501
Title: The role of antiandrogen monotherapy in the treatment of prostate cancer.
Journal: BJU international20030301
Title: Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.
Journal: Molecular pharmacology20030101
Title: Therapeutic androgen receptor ligands.
Journal: Nuclear receptor signaling20030101
Title: The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer.
Journal: British journal of cancer20021118
Title: Pneumonitis associated with nonsteroidal antiandrogens: presumptive evidence of a class effect.
Journal: Annals of internal medicine20021001
Title: Antiandrogen monotherapy: indications and results.
Journal: Urology20020901
Title: Prognostic factor analysis in patients with advanced prostate cancer treated by castration plus anandron or placebo: a final update.
Journal: European urology20020801
Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
Journal: The Journal of biological chemistry20020419
Title: [The role of bicalutamide in the treatment of prostate cancer].
Journal: Harefuah20020401
Title: Flavonoids can block PSA production by breast and prostate cancer cell lines.
Journal: Clinica chimica acta; international journal of clinical chemistry20020301
Title: [Respiratory side-effects of drugs].
Journal: Nederlands tijdschrift voor geneeskunde20020126
Title: Nilutamide: possible utility as a second-line hormonal agent.
Journal: Urology20011201
Title: Nilutamide-induced neutropenia.
Journal: BJU international20011101
Title: Antiandrogen monotherapy: a new form of treatment for patients with prostate cancer.
Journal: Urology20010801
Title: Why phase III trials of maximal androgen blockade versus castration in M1 prostate cancer rarely show statistically significant differences.
Journal: The Prostate20010615
Title: Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands.
Journal: Journal of medicinal chemistry20010524
Title: Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review.
Journal: Urology20010401
Title: Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function.
Journal: BJU international20010101
Title: Neither fibroblast growth factor-1 nor fibroblast growth factor-2 is an androgen receptor coactivator in androgen-resistant prostate cancer.
Journal: Molecular urology20010101
Title: Androgen deprivation and other treatments for advanced prostate cancer.
Journal: Reviews in urology20010101
Title: Flare Associated with LHRH-Agonist Therapy.
Journal: Reviews in urology20010101
Title: Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2.
Journal: Endocrinology20000201
Title: Comparison of in vitro effects of the pure antiandrogens OH-flutamide, Casodex, and nilutamide on androgen-sensitive parameters.
Journal: Urology19970401
Title: Is there a role for pure antiandrogens in the treatment of advanced prostatic cancer?
Journal: Progress in clinical and biological research19900101
Title: Harris MG, et al. Nilutamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer. Drugs Aging. 1993 Jan-Feb;3(1):9-25.
Title: Ask K, et al. Metabolism of nilutamide in rat lung. Biochem Pharmacol. 2006 Jan 12;71(3):377-85.
